News

Last year, a six-year-old Arkansas boy had to be put into a medically induced coma–after a tick bite gave him ehrlichiosis. At that time, according to his mom, “He lost all motor skills, all function, he couldn’t speak.” He began to have daily seizures, some of which... Read More »

by Dr. Eric Gordon Every day, we work with patients with complex chronic illnesses. Each individual is a puzzle, with varying symptoms and overlapping medical concerns. We know how hard it is to have complex health issues and so much confusing information out there. To continue... Read More »

From the Center for Lyme Action: The Fiscal Year 2024 Appropriations process has finally been completed. Congress has passed the second consolidated appropriations package and the President signed it into law on Saturday, March 23. The package includes funding for the Department... Read More »

By Anne Trafton, MIT News Lyme disease, a bacterial infection transmitted by ticks, affects nearly half a million people in the United States every year. In most cases, antibiotics effectively clear the infection, but for some patients, symptoms linger for months or years.... Read More »

The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research from University of California, San Francisco that offers potential clues to why some people develop long COVID. The... Read More »

Virginia’s General Assembly has unanimously passed a bill to make alpha-gal syndrome (AGS) reportable to the CDC. It now goes to the governor to be signed into law. AGS, triggered by the bite of a lone star tick, can make a person highly allergic to red meat and meat-related... Read More »

People often associate ticks with being in rural or suburban areas. But the infection-carrying arachnids can be found in densely populated cities as well. In a study recently published in the Journal of Medical Entomology, researchers collected 2500 ticks from parks in four New... Read More »

By Cynthia McCormick Hibbert, Northeastern University Human safety trials of a novel antibiotic treatment for Lyme disease developed by Northeastern professor Kim Lewis are scheduled to start this spring in Australia, with results anticipated by fall. “Hopefully, the results will... Read More »

U.S. Representatives Abigail Spanberger (Virginia) and Andrew R. Garbarino (New York) have introduced bipartisan legislation to allow for greater monitoring and reporting of alpha-gal syndrome (AGS) cases by the Centers for Disease Control and Prevention (CDC). Alpha-gal syndrome... Read More »